Skip to main content
ScholarsBetaWeill Cornell Medicine

Highlights

  1. 1
    Journal of vascular surgery. Venous and lymphatic disorders · 2020
    BDBrian DeRubertis
    PMID: 33248297DOISenior author18 citations
  2. 2
    Circulation · 2025
    BDBrian DeRubertis
    PMID: 40927852PMCID: PMC12513053DOIFirst author26 citations
  3. 3
    Annals of vascular surgery · 2026
    CAChristopher AgrusaSHSharif H. EllozyPCPeter ConnollyJRJordan Russell SternBDBrian DeRubertis
    PMID: 41903843DOISenior author

Publications

97 publications

Funding

1 grantView NIH portfolio on RePORTER ↗

Active

1 grant
  • Sub-PI
    Preventing major amputations and preserving functional limbs in no option critical limb-threating ischemia patients
    National Heart, Lung, and Blood Institute · 2025–2027 · via Aveera Medical, Inc.
    R44HL176399-02

Clinical research

9 studies

Active

7 studies
  • PI
    MAGICAL BTK: Randomized Controlled Trial of MAGIcTouch - Sirolimus Coated BALloon Versus Standard Balloon Angioplasty in The Treatment of Below The Knee Arterial Disease
    NA · Concept Medical Inc. · OPEN TO ACCRUAL (as of 2025)
    Arterial Disease of Legs; Below-the-knee Obstruction; PAD - Peripheral Arterial Disease
    NCT06182397
  • PI
    Bioresorbable Sirolimus-Eluting Scaffold Treatment for Below the Knee Disease
    NA · R3 VASCULAR INC · OPEN TO ACCRUAL (as of 2025)
    Chronic Limb-Threatening Ischemia
    NCT06071429
  • PI
    Esprit BTK Post-Approval Study (Esprit BTK PAS)
    NA · Abbott Laboratories, Inc. · OPEN TO ACCRUAL (as of 2025)
    Chronic Limb-Threatening Ischemia
    NCT06656364
  • PI
    Serranator OCT: Understanding the Mechanism of Action of Serration Angioplasty by Serranator Versus Conventional Balloon Angioplasty for below-the Knee (BTK) Artery Disease Using Optical Coherence Tomography (OCT)
    NA · Cagent Vascular, LLC · OPEN TO ACCRUAL (as of 2025)
    Critical Limb Ischemia
    NCT06434194
  • PI
    Pivotal Multicenter Trial of the Boomerang® Catheter for Percutaneous Deep Vein Arterialization (pDVA)
    NA · Aveera Medical, Inc. · OPEN TO ACCRUAL (as of 2025)
    Chronic Limb-Threatening Ischemia
    NCT06311773
  • PI
    Drug-Eluting Registry: Real-World Treatment of Lesions in the Peripheral Vasculature (ELEGANCE)
    Boston Scientific Corporation · OPEN TO ACCRUAL (as of 2023)
    Peripheral Vascular Diseases
    NCT04674969
  • PI
    Vessel Reconstruction for Malignant Sarcomas: Clinical Overview and Perioperative Outcomes at a Quaternary Institution
    Weill Medical College of Cornell University · OPEN TO ACCRUAL (as of 2022)
Completed & closed trials (2)
  • PI
    Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Chronic Limb-Threatening Ischemia: The PROMISE III Trial
    NA · LimFlow, Inc. · IRB STUDY CLOSURE (as of 2026)
    Critical Limb Ischemia; Chronic Limb-Threatening Ischemia; Peripheral Arterial Disease
    NCT05313165
  • PI
    JET Enhanced Thrombectomy Intervention Registry - JETi Registry
    Abbott Cardiovascular Systems, Inc. · IRB STUDY CLOSURE (as of 2025)
    Arterial Thrombosis
    NCT04370691

News mentions

1 mentionView all WCM news ↗
  • Absorbable Scaffold Outperforms Angioplasty for Lower-Leg Artery Disease
    November 13, 2023

    In patients with severe artery blockage in the lower leg, an artery-supporting device called a resorbable scaffold is superior to angioplasty, which has been the standard treatment, according to the results of a large international clinical trial co-led by researchers at Weill Cornell Medicine and NewYork-Presbyterian.

Media highlights

2 clips

External relationships

Other

Abbott Cardiovascular Systems, Inc. · Bard Peripheral Vascular, Inc. · Boston Scientific Corporation · Cagent Vascular, LLC · Medtronic Vascular, Inc. · Penumbra Inc